Differential regulation of cocaine-induced locomotor activity in inbred long-sleep and short-sleep mice by dopamine and serotonin systems

European Journal of Pharmacology

Volumn 502, Issue 3, 2004, Pages 221-231

  Hanania, Taleen ^a   McCreary, Andrew C ^b   Salaz, Danielle O ^b   Lyons, Anne M ^b   Zahniser, Nancy R ^b  

^a PSYCHOGENICS INC   (United States)

^b NONE

Author keywords

Cocaine; Dopamine receptor; Locomotor activity; Serotonin receptor

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; SEROTONIN 2 ANTAGONIST; SEROTONIN 3 ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG POTENTIATION; LOCOMOTION; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SLEEP;

ANIMALS; COCAINE; DOPAMINE ANTAGONISTS; FLUOXETINE; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SLEEP; SPECIES SPECIFICITY;

EID: 5044230590     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.09.001     Document Type: Article

References (60)

1. C.M. Andrews, and I. Lucki Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens Psychopharmacology 155 2001 221 229
2. S. Benloucif, and M.P. Galloway Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis Eur. J. Pharmacol. 200 1992 1 8
3. S. Benloucif, M.J. Keegan, and M.P. Galloway Serotonin-facilitated dopamine release in vivo: pharmacological characterization J. Pharmacol. Exp. Ther. 265 1993 373 377
4. J.A. Bourne SCH 23390: the first selective dopamine D1-like receptor antagonist CNS Drug Rev. 7 2001 399 414
5. A.R. Braun, and T.N. Chase Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors Eur. J. Pharmacol. 131 1986 301 306
6. P.A. Broderick, and C.F. Phelix I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT-DA interaction in cocaine dysfunctional behavior Neurosci. Biobehav. Rev. 21 1997 227 260
7. M.J. Bubar, L.R. McMahon, P. De Deurwaerdere, U. Spampinato, and K.A. Cunningham Selective serotonin reuptake inhibitors enhance cocaine-induced locomotor activity and dopamine release in the nucleus accumbens Neuropharmacology 44 2003 342 353
8. S. Cabib, C. Castellano, V. Cestari, U. Filibeck, and S. Puglisi-Allegra D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse Psychopharmacology 105 1991 335 339
9. P.M. Callahan, and K.A. Cunningham Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists Neuropharmacology 36 1997 373 381
10. R.J. Carey, G. DePalma, and E. Damianopoulos Cocaine and serotonin: a role for the 5-HT(1A) receptor site in the mediation of cocaine stimulant effects Behav. Brain Res. 126 2001 127 133
11. A.L. Chausmer, and J.L. Katz The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice Psychopharmacology 155 2001 69 77
12. R.N. Clark, C.R. Ashby Jr., S.L. Dewey, P.V. Ramachandran, and R.E. Strecker Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat Synapse 23 1996 125 131
13. K.A. Cunningham, and P.M. Callahan Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat Psychopharmacology 104 1991 177 180
14. K.A. Cunningham, and J.M. Lakoski The interaction of cocaine with serotonin dorsal raphe neurons, Single-unit extracellular recording studies Neuropsychopharmacology 3 1990 41 50
15. P. De Deurwaerdère, and U. Spampinato Role of serotonin(2A) and serotonin(2B/2C) receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation J. Neurochem. 73 1999 1033 1042
16. J.K. Dreher, and D.M. Jackson Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats Brain Res. 487 1989 267 277
17. A. Evrard, A.M. Laporte, M. Chastanet, R. Hen, M. Hamon, and J. Adrien HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knockout mice Eur. J. Neurosci. 11 1999 3823 3831
18. P.J. Fletcher, A.J. Grottick, and G.A. Higgins Differential effects of the 5-HT(2A) receptor antagonist M100907 and the 5-HT(2C) receptor antagonist SB242084 on cocaine-induced locomotor activity, cocaine self-administration and cocaine-induced reinstatement of responding Neuropsychopharmacology 27 2002 576 586
19. P.J. Fletcher, J. Sinyard, M. Salsali, and G.B. Baker Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects Psychopharmacology 2004 (Jan 22) (electronic publication)
20. C.A. Fornal, C.W. Metzler, R.A. Gallegos, S.C. Veasey, A.C. McCreary, and B.L. Jacobs WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135 J. Pharmacol. Exp. Ther. 278 1996 752 762
21. B. Giros, M. Jaber, S.R. Jones, R.M. Wightman, and M.G. Caron Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 1996 606 612
22. A.C. Glatz, M. Ehrlich, R.S. Bae, M.J. Clarke, P.A. Quinlan, E.C. Brown, P. Rada, and B.G. Hoebel Inhibition of cocaine self-administration by fluoxetine or d-fenfluramine combined with phentermine Pharmacol. Biochem. Behav. 71 2002 197 204
23. T. Hanania, and N.R. Zahniser Locomotor activity induced by noncompetitive NMDA receptor antagonists versus dopamine transporter inhibitors: opposite strain differences in inbred long-sleep and short-sleep mice Alcohol., Clin. Exp. Res. 26 2002 431 440
24. T. Hanania, A.C. McCreary, H.M. Haughey, D.O. Salaz, and N.R. Zahniser MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems Eur. J. Pharmacol. 457 2002 125 135
25. T. Hanania, J.M. Gulley, D.O. Salaz, G.A. Larson, and N.R. Zahniser Role of the dopamine transporter in the differential cocaine-induced locomotor activation of inbred long-sleep and short-sleep mice Neuropsychopharmacology 2004 (June) (electronic publication)
26. S. Herges, and D.A. Taylor Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat Pharmacol. Biochem. Behav. 59 1998 595 611
27. S. Herges, and D.A. Taylor Modulation of cocaine-induced locomotor activity, rears and head bobs by application of WAY100635 into the dorsal and median raphe nuclei of the rat Naunyn-Schmiedeberg's Arch. Pharmacol. 360 1999 129 134
28. S. Herges, and D.A. Taylor Involvement of 5-HT(3) receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviors in the rat Br. J. Pharmacol. 131 2000 1294 1302
29. A. Kankaanpää, P. Lillsunde, M. Ruotsalainen, L. Ahtee, and T. Seppälä 5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum Pharmacol. Toxicol. 78 1996 317 321
30. A. Kankaanpää, E. Meririnne, and T. Seppälä 5-HT3 receptor antagonist MDL 72222 attenuates cocaine- and mazindol-, but not methylphenidate-induced neurochemical and behavioral effects in the rat Psychopharmacology 159 2002 341 350
31. P.H. Kelly, and S.D. Iversen Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats Eur. J. Pharmacol. 40 1976 45 56
32. G.R. King, Z. Xiong, and E.H. Ellinwood Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration Eur. J. Pharmacol. 364 1999 79 87
33. G.R. King, Z. Xiong, S. Douglass, and E.H. Ellinwood Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist Eur. J. Pharmacol. 394 2000 97 101
34. K. Kita, T. Shiratani, K. Takenouchi, H. Fukuzako, and M. Takigawa Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats Eur. Neuropsychopharmacol. 9 1999 1 7
35. P.D. Markel, J.C. Defries, and T.E. Johnson Use of repeated measures in an analysis of ethanol-induced loss of righting reflex in inbred long-sleep and short-sleep mice Alcohol., Clin. Exp. Res. 19 1995 299 304
36. J.F. Marwood Influence of alpha 1-adrenoceptor antagonism of ketanserin on the nature of its 5-HT2 receptor antagonism Clin. Exp. Pharmacol. Physiol. 21 1994 955 961
37. G.E. McClearn, and R. Kakihana Selective breeding for ethanol sensitivity: LS and SS mice G.E. McClearn R.A. Deitrich V.G. Erwin Development of Animal Models as Pharmacogenetic Tools 1981 Government Printing Office Washington, DC 147 159
38. A.C. McCreary, and C.A. Marsden Cocaine-induced behaviour: dopamine D1 receptor antagonism by SCH 23390 prevents expression of conditioned sensitisation following repeated administration of cocaine Neuropharmacology 32 1993 387 391
39. L.R. McMahon, and K.A. Cunningham Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats J. Pharmacol. Exp. Ther. 297 2001 357 363
40. L.R. McMahon, M. Filip, and K.A. Cunningham Differential regulation of the mesoaccumbens circuit by serotonin 5-hydroxytryptamine (5-HT)2A and 5-HT2C receptors J. Neurosci. 21 2001 7781 7787
41. C.S. McNeish, A.L. Svingos, R. Hitzemann, and R.E. Strecker The 5-HT3 antagonist zaclopride attenuates cocaine-induced increases in extracellular dopamine in rat nucleus accumbens Pharmacol. Biochem. Behav. 45 1993 759 763
42. M.J. Millan, A. Newman-Tancredi, Y. Quentric, and D. Cussac The 'selective" dopamine D1 receptor antagonist, SCH 23390, is a potent and high efficacy agonist at cloned human serotonin2C receptors Psychopharmacology 156 2001 58 62
43. C.P. Müller, M.A. De Souza Silva, G. DePalma, C. Tomaz, R.J. Carey, and J.P. Huston The selective serotonin(1A)-receptor antagonist WAY 100635 blocks behavioral stimulating effects of cocaine but not ventral striatal dopamine increase Behav. Brain Res. 134 2002 337 346
44. M.G. Palfreyman, C.J. Schmidt, S.M. Sorensen, M.W. Dudley, J.H. Kehne, P. Moser, M.W. Gittos, and A.A. Carr Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function Psychopharmacology 112 1993 S60 S67
45. L.H. Parsons, and J.B. Justice Jr. Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis Brain Res. 606 1993 195 199
46. M.E. Reith 5-HT3 receptor antagonists attenuate cocaine-induced locomotion in mice Eur. J. Pharmacol. 186 1990 327 330
47. M.E. Reith, H.L. Wiener, and C.T. Fischette Sertraline and cocaine-induced locomotion in mice: I. Acute studies Psychopharmacology 103 1991 297 305
48. N.R. Richardson, and D.C. Roberts Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat Life Sci. 49 1991 833 840
49. M.C. Ritz, E.J. Cone, and M.J. Kuhar Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structureâ €"activity study Life Sci. 46 1990 635 645
50. B.A. Rocha, F. Fumagalli, R.R. Gainetdinov, S.R. Jones, R. Ator, B. Giros, G.W. Miller, and M.G. Caron Cocaine self-administration in dopamine-transporter knockout mice Nat. Neurosci. 1 1998 132 137
51. T.L. Sills, A.J. Greenshaw, G.B. Baker, and P.J. Fletcher The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin Psychopharmacology 143 1999 426 432
52. I. Sora, F.S. Hall, A.M. Andrews, M. Itokawa, X.F. Li, H.B. Wei, C. Wichems, K.P. Lesch, D.L. Murphy, and G.R. Uhl Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference Proc. Natl. Acad. Sci. U. S. A. 98 2001 5300 5305
53. S.M. Sorensen, T.M. Humphreys, and M.G. Palfreyman Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons Eur. J. Pharmacol. 163 1989 115 118
54. E.A. Stone, H. Rosengarten, Y. Lin, and D. Quartermain Pharmacological blockade of brain alpha1-adrenoceptors as measured by ex vivo [3H]prazosin binding is correlated with behavioral immobility Eur. J. Pharmacol. 450 2001 97 102
55. A.L. Svingos, and R. Hitzemann 5-HT3 receptor antagonists block cocaine-induced locomotion via a PCPA-sensitive mechanism Pharmacol. Biochem. Behav. 43 1992 871 879
56. L.M. Teneud, T. Baptista, E. Murzi, B.G. Hoebel, and L. Hernandez Systemic and local cocaine increase extracellular serotonin in the nucleus accumbens Pharmacol. Biochem. Behav. 53 1996 747 752
57. I. Ushijama, M.A. Carino, and A. Horita Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats Pharmacol. Biochem. Behav. 52 1995 737 741
58. R.A. Wise, and M.A. Bozarth A psychomotor stimulant theory of addiction Psychol. Rev. 94 1987 469 492
59. M. Xu, X.T. Hu, D.C. Cooper, R. Moratalla, A.M. Graybiel, F.J. White, and S. Tonegawa Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice Cell 79 1994 945 955
60. K. Yoshimoto, and W.J. McBride Regulation of nucleus accumbens dopamine release by the dorsal raphe nucleus in the rat Neurochem. Res. 17 1992 401 407